Flavia Nicoli

Dr. Flavia Nicoli


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2024 in Medicina
Verified
Journal Article
Open access
PDF file
MMMaria Lo Monaco
Maria Lo Monaco
KSKamil Stankowski
Kamil Stankowski
SFStefano Figliozzi
Stefano Figliozzi
FNFlavia Nicoli
Flavia Nicoli
VSVincenzo Scialò
Vincenzo Scialò
MFMarco Francone
Marco Francone
Risk stratification for malignant ventricular arrhythmias and sudden cardiac death is a daunting task for physicians in daily practice. Multiparametric mapping sequences obtained via cardiovascular magnetic resonance imaging can improve the risk stratification for malignant ventricular arrhythmias by unveiling the presence of pathophysiological pro-arrhythmogenic processes. However, their employment in clinical practice is still restricted. The present review explores the current evidence supporting the association between mapping abnormalities and the risk of ventricular arrhythmias in several cardiovascular diseases. The key message is that further clinical studies are needed to test the additional value of mapping techniques beyond conventional cardiovascular magnetic resonance imaging for selecting patients eligible for an implantable cardioverter defibrillator.

28 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMaria Lo Monaco
Maria Lo Monaco
KSKamil Stankowski
Kamil Stankowski
SFStefano Figliozzi
Stefano Figliozzi
FNFlavia Nicoli
Flavia Nicoli
VSVincenzo Scialò
Vincenzo Scialò
MFMarco Francone
Marco Francone
Risk stratification for malignant ventricular arrhythmias and sudden cardiac death is a daunting task for physicians in daily practice. Multiparametric mapping sequences obtained via cardio-vascular magnetic resonance imaging can improve the risk for malignant ventricular arrhythmias by unveiling the presence of pathophysiological pro-arrhythmogenic processes. However, their employment in clinical practice is still restricted. The present review explores the current evidence supporting the association between mapping abnormalities and the risk of ventricular arrhyth-mias in several cardiovascular diseases. The key message is that further clinical studies are needed to test the additional value of mapping techniques beyond conventional cardiovascular magnetic resonance imaging for selecting patients eligible for an implantable cardioverter defibrillator.

3 September 2025 in JACC: Case Reports
Verified
Journal Article
Open access
FNFlavia Nicoli
Flavia Nicoli
CECollaku Elona
Collaku Elona
MRMollace Rocco
Mollace Rocco
LMLicastro Margherita
Licastro Margherita
BEBertella Erika
Bertella Erika
We present a multimodality imaging study of a rare case of postsurgical chronically evolved pseudoaneurysm with a possible rupture buffered by the huge thrombus. A patient known for previous late presentation myocardial infarction complicated by shock and ventricular septal defect and treated with surgical repair and triple coronary artery bypass grafting, was directed to our hospital for severe mitral regurgitation. Computed tomography, cardiac magnetic resonance, and echocardiography, in a multimodality approach, revealed a huge postsurgical cardiac pseudoaneurysm, with an extensive thrombus and the native pericardium not perfectly distinguishable from pseudoaneurysm tissue or surgical patch. All the tissue characteristics were supporting a chronically evolved pseudoaneurysm following detachment of the ventricular surgical patch, with a possible rupture buffered by the huge floating thrombus, complicated by ischemic stroke and severe mitral regurgitation. Computed tomography and cardiac magnetic resonance images can provide precise details for interventional planning, cardiac volume and function, and tissue characterization. Multimodality imaging could be essential for evaluation of complex cases.

15 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MMMaria Lo Monaco
Maria Lo Monaco
MLMargherita Celeste Licastro
Margherita Celeste Licastro
Matteo NardinMatteo Nardin
Matteo Nardin
RMRocco Mollace
Rocco Mollace
FNFlavia Nicoli
Flavia Nicoli
EBErika Bertella
Erika Bertella
Background: The widespread use of cardiac magnetic resonance imaging (MRI) in clinical practice has enabled the identification of numerous patients with evident damage from previous myocarditis, whether known or unknown. For years, myocardial fibrosis has been a topic of interest due to its established correlation with arrhythmic events in various clinical settings, including ischemic heart disease, dilated cardiomyopathy, and hypertrophic cardiomyopathy. MIBG scintigraphy is a method widely used in patients who are candidates for defibrillator implantation or have experienced heart failure. This examination evaluates the sympathetic innervation of the myocardium. Objective: To assess the real arrhythmogenic risk of non-ischemic scars identified in symptomatic or asymptomatic patients through the use of MIBG. Methods: Patients were retrospectively selected based on the presence of non-ischemic myocardial fibrosis detected by cardiac MRI, consistent with a myocarditis outcome (even in the absence of a clear history of myocarditis). These patients underwent myocardial scintigraphy with MIBG using a tomographic technique. Results: A total of 50 patients (41 males, mean age 51 ± 16 years) who underwent MRI from 2019 to June 2024 were selected. The primary indication for MRI was ventricular ectopic extrasystoles detected on Holter ECG (n = 12, 54%), while five patients underwent MRI following a known acute infectious event (23%, including three cases of COVID-19 infection). All symptomatic patients presented with chest pain in the acute phase, accompanied by elevated hsTNI levels (mean value: 437 pg/mL). The MRI findings showed normal ventricular volumes (LV: 80 mL/m2, RV: 81 mL/m2) and normal ejection fractions (56% and 53%, respectively). The mean native T1 mapping value was 1013 ms (normal range: 950–1050). T2 mapping values were altered in the 5 patients who underwent MRI during the acute phase (mean value: 57 ms), without segmentation. Additionally, three patients had non-tamponade pericardial effusion. All patients exhibited LGE (nine subepicardial, seven midwall, six patchy). All patients underwent myocardial scintigraphy with MIBG at least 6 months after the acute event, with only one case yielding a positive result. This patient, a 57-year-old male, had the most severe clinical presentation, including more than 65,000 premature ventricular beats (PVBs) and multiple episodes of paroxysmal supraventricular tachycardia (PSVT) recorded on Holter ECG. MRI findings showed severe left ventricular dysfunction, a slightly dilated LV, and midwall LGE at the septum, coinciding with hypokinetic areas. Conclusions: MIBG scintigraphy could be a useful tool in assessing arrhythmic risk in patients with previous myocarditis. It could help reduce the clinical burden of incidental findings of non-ischemic LGE, which does not appear to be independently associated with an increased risk profile.

27 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
FNFlavia Nicoli
Flavia Nicoli
RMRocco Mollace
Rocco Mollace
ECElona Collaku
Elona Collaku
MMMaria Lo Monaco
Maria Lo Monaco
MLMargherita Celeste Licastro
Margherita Celeste Licastro
EBErika Bertella
Erika Bertella
Advances in computed tomography (CT) technology have made it possible to perform non-invasive imaging with detailed characterization and quantification of the myocardium. Cardiac CT (CCT) has emerged as a technique useful for providing deeper insights into cardiovascular diseases, as a valuable alternative when cardiac magnetic resonance imaging or echocardiography are contraindicated, technically unfeasible, inconclusive, or non-diagnostic. Cardiac tissue characterization by the advances in CT technology lead to differentiate myocardial tissue types with high resolution. CCT allows the assessment of tissue properties such as myocardial perfusion, fibrosis and fat infiltration, which are critical in diagnosing ischemic heart disease, microvascular obstruction, heart failure, cardiomyopathies, and other cardiac conditions 1. Thin surgical complications and prosthesis studies are possible through high resolution scanners, allowing to detect HALT, pannus, thrombosis, endocarditis, abscesses and other characterizations. The use of contrast agents, along with advanced imaging techniques such as photon-counting CT, allows for high-resolution imaging of tissue heterogeneity, making it a valuable tool for non-invasive evaluation. Dual-energy computed tomography (DECT) has emerged as a transformative tool in the non-invasive assessment of cardiac tissue, enabling a more precise characterization of myocardial structures and pathologies. Employing two distinct energy levels, it provide unique advantages in tissue differentiation through the energy-dependent attenuation of various tissues, allowing for better delineation of tissue properties such as fat, fibrosis, calcification, and water content, improving also quantitative imaging and iodine mapping. Furthermore, new methodologies like CT-based tissue characterization models and artificial intelligence algorithms are enhancing the accuracy of differentiating normal and pathological cardiac tissues. The integration of cardiac CT with other imaging modalities, such as cardiac magnetic resonance (CMR), is also highlighted as a promising approach for comprehensive cardiac tissue assessment in several clinical settings. [*] Aim and scope of the Special Issue: This paper reviews the current techniques for cardiac tissue characterization using CT, explores the role of texture analysis, and discusses the challenges in achieving precise tissue differentiation, outlining the current applications and future perspective of cardiac CT in myocardial tissue characterization.

25 May 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MBMatteo Brusamolino
Matteo Brusamolino
FCFrancesco Catagnano
Francesco Catagnano
MMMaria Lo Monaco
Maria Lo Monaco
SMSilvia Malara
Silvia Malara
MCMatteo De Carli
Matteo De Carli
EBErika Bertella
Erika Bertella
Infiltrative cardiomyopathies comprise a heterogeneous spectrum of hereditary and acquired diseases characterised by the accumulation of pathological substrates within the myocardium, ultimately resulting in progressive impairment of cardiac function and the development of heart failure. Across these conditions, atrial fibrillation is a frequent and clinically relevant complication, contributing to symptom burden, heart failure progression, and thromboembolic risk. Structural, functional, and electrical atrial remodelling, collectively referred to as atrial cardiomyopathy, emerges as a common pathophysiological substrate linking myocardial infiltration to atrial fibrillation and adverse cardiovascular outcomes. Multi-modality cardiac imaging enables comprehensive assessment of atrial cardiomyopathy, offering mechanistic insights into the atrial substrate of atrial fibrillation, with potential impact on the clinical management of this group of diseases. This review summarises contemporary evidence on atrial fibrillation in infiltrative cardiomyopathies, with a particular focus on the role of non-invasive multimodal imaging in the evaluation of atrial cardiomyopathy.